B
BLPH
vs
ABT
ABT
Over the past 12 months, BLPH has underperformed ABT, delivering a return of 0% compared to the ABT's 16% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ABT
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc
OTC:BLPH
|
0.1025
USD
|
|||||
|
Abbott Laboratories
NYSE:ABT
|
110.43
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
BLPH, ABT
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
B
|
Bellerophon Therapeutics Inc
Revenue
|
|||||||||||
|
Abbott Laboratories
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
BLPH, ABT
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
B
|
Bellerophon Therapeutics Inc
OTC:BLPH
|
|||||||||
|
Abbott Laboratories
NYSE:ABT
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Abbott Laboratories | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Abbott Laboratories | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Abbott Laboratories | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Abbott Laboratories | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Abbott Laboratories | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Abbott Laboratories | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Abbott Laboratories | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Bellerophon Therapeutics Inc | ||||
|
Abbott Laboratories | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
BLPH, ABT
Performance By Year
BLPH, ABT
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Abbott Laboratories
NYSE:ABT
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
|
| US |
|
Resmed Inc
NYSE:RMD
|